PolyPid's product for preventing surgical site infection failed to achieve its primary endpoint, although results for one subgroup of patients were more encouraging.
Trendlines has a novel approach to investing in early-stage companies. There are multiple portfolio companies nearing exit stage. Read more on TRNLY stock here.
/PRNewswire/ SetBone Medical Ltd., a company that has developed a novel bone cement for the treatment of spinal vertebrae fractures and other orthopedic.